|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma 显示文摘 | Saad K Gleason DM Murray R | 2002 | J Natl Cancer Inst2002，94，19： | 1 |
| 2 | A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma 显示文摘 | Saad F Gleason DM Murray R | 2002 | J Natl CancerInst2002，94，19： | 1 |
| 3 | A randomized,placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma显示文摘 | Saad F Gleason DM Murray R | 2002 | J Natl Cancer Inst2002，94，19： | 1 |
| 4 | A randomized, placebo -controlled trial of zoledronic acid in patients with hormone - refractory metastatic prostate carcinoma显示文摘 | Saad F Gleason DM Murray R | 2002 | J Natl Cancer Inst2002，94，19： | 1 |
| 5 | Long-term efficacy of zoledron-ic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer显示文摘 | Saad F Gleason DM Murray R | 2004 | J Natl Cancer Inst2004，96，12： | 1 |
| 6 | A randomized,placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma,Zoledronic Acid prostate cancer Study Group显示文摘 | SAAD F GLEASON DM MURRAY R | 2002 | J Natl Cancer Inst2002，94，19： | 1 |
| 7 | Arandominsed, place boeontrolled trial of zoledronicaeid in patients with hormonere fraetory metastatic prostate carcinoma, Zoledronie Acid Prostate Cancer Study Group显示文摘 | Saad F Gleason DM Murray R | 2002 | J Natl Cancer Inst2002，94，19： | 1 |
| 8 | Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer显示文摘 | Smith MR Eastham J Gleason DM | 2003 | J Urol2003，169，6： | 1 |
| 9 | Long - term efficacy of zole-dronic acid for the prevention of skeletal complications in patients with metastatic hormone- refractory prostate cancer显示文摘 | Saad F Gleason DM Murray R | 2004 | J Natl Cancer Inst2004，96，11： | 1 |
| 10 | Lone-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer 显示文摘 | Saad F Gleason DM Murray R | 2004 | J Natl cancer Inst2004，96，11： | 1 |
| 11 | Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer 显示文摘 | Smith MR Eastham J Gleason DM | 2003 | J Urol2003，169，6： | 1 |
| 12 | A randominsed,placebo-controlled trial of zoledronic acid in patients with hormonerefractory metastatic prostate carcinoma:Zoledronic Acid Prostate Cancer Study Group显示文摘 | Saad F Gleason DM MurrarR | 2002 | J Natl Cancer Inst2002，94，19： | 1 |
| 13 | A randomized, placebo- controlled trial of zoledronic acid in patientswith hormone-refractorymetastatic prostate carcinoma显示文摘 | Saad F Gleason DM Murray R | 2002 | JNatlCancer Inst2002，94，19： | 1 |
| 14 | A randomized placebocontrolled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma显示文摘 | Saad F Gleason DM Murray R | 2002 | J Natl Cancer Inst2002，94，19： | 1 |
| 15 | A randomized, placebo- controlled trial of zoledronic acid in patients with hormone- refractory metastatic prostate carcinoma 显示文摘 | Saad F Gleason DM Murray R | 2002 | J Natl Cancer Inst2002，94，19： | 1 |
| 16 | A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma 显示文摘 | Gleason DM Murray R | 2002 | J Natl Cancer Inst2002，94，19： | 1 |
| 17 | A randomized, placebo - controlled trial of zoledronic acid in patients with hormone - re- fractory metastatic prostate carcinoma 显示文摘 | Saad F Gleason DM Murray R | 2002 | J Natl Cancer Inst2002，94，19： | 1 |
| 18 | A randomized placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma显示文摘 | Saad F Gleason DM Murray R | | 0，，： | 1 |
| 19 | A randomized placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma显示文摘 | Sadd F Gleason DM Murray R | 2002 | 1 Natl Cancer Inst2002，94，19： | 1 |
| 20 | Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer 显示文摘 | Saad F Gleason DM Murray R | 2004 | J Natl Cancer Lust2004，96，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员